General Information


DRACP ID  DRACP04167

Peptide Name  

Sequence  GWYEIIKKIYKWLK

Sequence Length  14

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C95H142N20O19

Absent amino acids  ACDFHMNPQRSTV

Common amino acids  K

Mass  210036

Pl  10.24

Basic residues  4

Acidic residues  1

Hydrophobic residues  6

Net charge  3

Boman Index  -401

Hydrophobicity  -47.14

Aliphatic Index  111.43

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  13980

Absorbance 280nm  1075.38

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30506920

Title  Simulated Molecular Evolution for Anticancer Peptide Design

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  17985

DRACP is developed by Dr.Zheng's team.